Extendicare Stock Market Value
| EXETF Stock | USD 16.00 0.19 1.17% |
| Symbol | Extendicare |
Extendicare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Extendicare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Extendicare.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in Extendicare on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Extendicare or generate 0.0% return on investment in Extendicare over 180 days. Extendicare is related to or competes with Netcare, RHÖN-KLINIKUM Aktiengesellscha, WashTec AG, Life Healthcare, Panamera Holdings, Arjo AB, and Safilo Group. Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada More
Extendicare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Extendicare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Extendicare upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.8 | |||
| Information Ratio | 0.252 | |||
| Maximum Drawdown | 16.44 | |||
| Value At Risk | (1.91) | |||
| Potential Upside | 3.66 |
Extendicare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Extendicare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Extendicare's standard deviation. In reality, there are many statistical measures that can use Extendicare historical prices to predict the future Extendicare's volatility.| Risk Adjusted Performance | 0.2091 | |||
| Jensen Alpha | 0.6084 | |||
| Total Risk Alpha | 0.4153 | |||
| Sortino Ratio | 0.3171 | |||
| Treynor Ratio | 1.36 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Extendicare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Extendicare Backtested Returns
Extendicare appears to be not too volatile, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.29, which denotes the company had a 0.29 % return per unit of risk over the last 3 months. By reviewing Extendicare's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please utilize Extendicare's Downside Deviation of 1.8, coefficient of variation of 347.92, and Mean Deviation of 1.39 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Extendicare holds a performance score of 22. The firm shows a Beta (market volatility) of 0.47, which means possible diversification benefits within a given portfolio. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's semi variance, and the relationship between the maximum drawdown and daily balance of power , to make a quick decision on whether Extendicare's price patterns will revert.
Auto-correlation | 0.45 |
Average predictability
Extendicare has average predictability. Overlapping area represents the amount of predictability between Extendicare time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Extendicare price movement. The serial correlation of 0.45 indicates that just about 45.0% of current Extendicare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.45 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 2.27 |
Extendicare lagged returns against current returns
Autocorrelation, which is Extendicare pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Extendicare's pink sheet expected returns. We can calculate the autocorrelation of Extendicare returns to help us make a trade decision. For example, suppose you find that Extendicare has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Extendicare regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Extendicare pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Extendicare pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Extendicare pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Extendicare Lagged Returns
When evaluating Extendicare's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Extendicare pink sheet have on its future price. Extendicare autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Extendicare autocorrelation shows the relationship between Extendicare pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Extendicare.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Extendicare Pink Sheet
Extendicare financial ratios help investors to determine whether Extendicare Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.